Jakob Admard

10PUBLICATIONS
121CO-AUTHORS
Predictive and prognostic markersGene mappingFoetal development and medicineMolecular targetsGenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 09, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Elena Sophia Lindner, Jakob Admard, German Demidov

|Feb 14, 2026
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia.

Benita Menden, Rana D Incebacak Eltemur, German Demidov

|Dec 12, 2024
Harnessing 2D and 3D human endometrial cell culture models to investigate SARS-CoV-2 infection in early pregnancy.

Anna Liu, Natalia Ruetalo, Janet P Raja Xavier

|Oct 09, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition.

Christopher Schroeder, Sergios Gatidis, Olga Kelemen

|Apr 29, 2024
A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy.

Karla P Figueroa, Caspar Gross, Elena Buena-Atienza

Pageof 2